Entegrion, Inc.

UEI: LLK3BJBGY2J5
CAGE: 37RF4
Primary NAICS: 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
SAM.gov registration: Expired Apr 3, 2026

Company facts

Self-certified in SAM.gov: For Profit Organization

Manufacturer of Goods
Entity structure: Corporate Entity (Not Tax Exempt)
SAM.gov registration date: Mar 23, 2005
Website: entegrion.com
Founded: 2002
Employees: 11-50
Estimated annual revenue: $1M-$10M
Industry: Health Care

Pharmaceuticals, Biotechnology & Life Sciences

Pharmaceuticals
SIC code: 28 Chemical & Allied Products
Profiles: LinkedIn

X

Crunchbase

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated Apr 3, 2026.

Award	Agency	Obligated	Awarded
Funding for clin 0001 W81XWH16C0162	Medical Command (Army)	$18,250,856	Sep 28, 2016
120 stasix and 53 resusix delivery for the base period and 120 stasix and 53 resusix for the first option period… N6264515P3109	Bureau of Medicine and Surgery (Navy)	$33,500	Sep 30, 2015
Advanced development of stasix W81XWH14C1388	Medical Command (Army)	$3,757,860	Sep 26, 2014
Stasix, one batch of stasix - quantity N3239814P0101	Bureau of Medicine and Surgery (Navy)	$13,120	Jan 31, 2014
Long range broad agency announcement (BAA) for navy and marine corps science and technology N0001413C0260	Office of Naval Research (SECNAV)	$3,108,064	Aug 28, 2013

Award	Agency	Obligated	Awarded
Development of a hand held thromboelastograph W81XWH1120015	Department of Defense	$2,771,002	Dec 20, 2010

From the vendor's SBA profile

Biotechnology research and development specializing in products for hemostasis and/or blood related diseases

Entegrion, Inc.'s SAM.gov registration expired on April 3, 2026.

Entegrion, Inc.'s most recent federal contract award is Funding for clin 0001 (W81XWH16C0162), from Medical Command (Army), on September 28, 2016.

On GovTribe

Try for free Login